CIBC Bancorp USA’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$18.2M Sell
46,801
-7,013
-13% -$2.96M 0.02% 431
2026
Q1
$25.5M Buy
+53,814
New +$27.1M 0.03% 333
2025
Q3
$9.89M Buy
+23,194
New +$8.99M 0.05% 262

Other funds holding HCA

CIBC Bancorp USA's HCA Position: Q2 2026 in Review

CIBC Bancorp USA reduced its HCA Healthcare (HCA) stake by 13% in Q2 2026, selling an estimated $2.96M and leaving 46,801 shares worth $18.2M. The position accounts for 0.02% of the portfolio, ranked #431.

CIBC Bancorp USA first reported a position in HCA in Q3 2025 and has held it in 3 quarters since. The position peaked at $25.5M in Q1 2026. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • CIBC Bancorp USA held 46,801 shares of HCA Healthcare worth $18.2M as of Q2 2026.
  • CIBC Bancorp USA sold 7,013 HCA Healthcare shares in Q2 2026, an estimated $2.96M.
  • HCA Healthcare made up 0.02% of CIBC Bancorp USA's portfolio in Q2 2026, its #431 holding.
  • CIBC Bancorp USA first reported a position in HCA Healthcare in Q3 2025 and has held it in 3 quarters since.
  • CIBC Bancorp USA's HCA Healthcare position peaked at $25.5M in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.